ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Abionyx Pharma

Abionyx Pharma (ABNX)

1.248
-0.002
( -0.16% )
Updated: 04:45:45

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.248
Bid
1.234
Ask
1.248
Volume
552
1.228 Day's Range 1.248
0.91 52 Week Range 1.482
Market Cap
Previous Close
1.25
Open
1.24
Last Trade
200
@
1.248
Last Trade Time
04:47:00
Financial Volume
-
VWAP
-
Average Volume (3m)
70,865
Shares Outstanding
32,459,012
Dividend Yield
-
PE Ratio
-11.53
Earnings Per Share (EPS)
-0.11
Revenue
4.74M
Net Profit
-3.52M

About Abionyx Pharma

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Balma, Haute-garonne, Fra
Founded
1970
Abionyx Pharma is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ABNX. The last closing price for Abionyx Pharma was 1.25 €. Over the last year, Abionyx Pharma shares have traded in a share price range of 0.91 € to 1.482 €.

Abionyx Pharma currently has 32,459,012 shares outstanding. The market capitalization of Abionyx Pharma is 40.57 € million. Abionyx Pharma has a price to earnings ratio (PE ratio) of -11.53.

ABNX Latest News

ABIONYX Pharma : Bilan semestriel du contrat de liquidité contracté avec la Société TP ICAP (Europe) SA

Regulatory News: Au titre du contrat de liquidité confié par la société ABIONYX Pharma (Paris:ABNX) à la Société TP ICAP (Europe) SA, à la date du 28 juin 2024, les moyens suivants figuraient au...

ABIONYX Pharma : Information relative au nombre total de droits de vote et d’actions composant le capital social

Regulatory News: ABIONYX Pharma (Paris:ABNX): Place de cotation : Euronext Paris, Compartiment C Code ISIN : FR0012616852 Date Nombre de titres composant le capital en circulation Nombre total de...

ABIONYX Carries out Successfully a Capital Increase With Cancellation of Preferential Subscription Rights for the Benefit of a Category of Persons Through the Issue of Shares With Warrants for an Amount of c.€3.4 Million

c.€3.4 million by issuing shares with warrants Subscription price: €1.37 for one share with warrants 1 warrant gives entitlement to 1 share to be issued at a price of €3 Exercise period: 3 years...

ABIONYX Pharma announces unanimous approval of all resolutions put to the vote at its Combined General Meeting

Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world’s...

ABIONYX décide une augmentation de capital avec suppression du droit préférentiel de souscription au profit d’une catégorie de personnes par émission d’ABSA d’un montant d’environ 3,4M€

Montant d’environ 3,4 millions d'euros par émission d’actions assorties de bons de souscription d’actions (« ABSA ») Prix de souscription : 1,37 euro pour une ABSA 1 BSA donne droit à 1 action à...

ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis

Based on encouraging Phase 2a data and a productive pre-IND Type B meeting with U.S. Food and Drug Administration (FDA), ABIONYX Pharma intends to file an Investigational New Drug application...

ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis

Based on encouraging Phase 2a data and a productive pre-IND Type B meeting with U.S. Food and Drug Administration (FDA), ABIONYX Pharma intends to file an Investigational New Drug application...

ABIONYX : Information relative au nombre total de droits de vote et d’actions composant le capital social

Regulatory News: ABIONYX Pharma (Paris:ABNX): Place de cotation : Euronext Paris, Compartiment C Code ISIN : FR0012616852 Date Nombre de titres composant le capital en circulation Nombre total de...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0080.6451612903231.241.251.202145591.23042176DE
40.032.463054187191.2181.251.11210531.20037335DE
120.22622.11350293541.0221.4821.006708651.24027384DE
26-0.012-0.9523809523811.261.4820.91594631.17744865DE
520.0383.140495867771.211.4820.91731901.22177175DE
1560.208201.043.570.911744471.98184162DE
2600.918278.1818181820.333.570.22516001.36798552DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WRNTWarrantee Inc
$ 0.8962
(207.97%)
11.84M
NMHINatures Miracle Holding Inc
$ 0.7982
(128.06%)
8.33M
FEIMFrequency Electronics Inc
$ 13.37
(32.38%)
122.96k
TUSKMammoth Energy Services Inc
$ 4.51
(28.86%)
74.15k
LGHLWLion Group Holding Ltd
$ 0.0091
(28.17%)
4.5k
RNAZTransCode Therapeutics Inc
$ 0.3236
(-59.17%)
434.09k
MIRAMIRA Pharmaceuticals Inc
$ 3.49
(-30.34%)
1M
BREABrera Holdings PLC
$ 0.5495
(-25.45%)
1.77M
CMAXCareMax Inc
$ 3.89
(-25.05%)
336.59k
NUKKNukkleus Inc
$ 0.4089
(-17.89%)
161.42k
WRNTWarrantee Inc
$ 0.8865
(204.64%)
11.88M
NMHINatures Miracle Holding Inc
$ 0.7997
(128.49%)
8.33M
LIFWMSP Recovery Inc
$ 0.5111
(0.87%)
4.7M
BREABrera Holdings PLC
$ 0.5495
(-25.45%)
1.77M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 14.48
(1.33%)
1.51M

Discussion

View Full Feed
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
Interesting
ZHUD
JOoa0ky JOoa0ky 6 minutes ago
The assault on the legal front has failed and it's over.

It's time to turn the focus towards admin action.
FNMA
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
Maybe a judge would cancel shares like Z??D
INDR
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
Would make a great reverse merger
INDR
trade2brich trade2brich 7 minutes ago
Wow????? 667,260 x .0005 = $333….that’s it….says it all. I spent more on dinner last night
ERBB
TRUSTUNITS1000000 TRUSTUNITS1000000 7 minutes ago
Shareholders post
INDR
TRUSTUNITS1000000 TRUSTUNITS1000000 7 minutes ago
Getting interesting
INDR
TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
Shareholders post
TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
Terrible what happened here
Implanting Implanting 8 minutes ago
Ultimately, the sentiment change comes with a higher gold price. We get the big move higher in gold when the recession hits and fear in the stock markets finally rear its ugly head. Panic will ensue and as usual, there will be a flight to safety. That means selling of the tech sector, which is in a
FFMGF
learningcurve2020 learningcurve2020 9 minutes ago
That right there makes oncologist skeptical.

>>It baffles me as well. DCVax has a safety profile similar to drinking water.
NWBO
pepeoil pepeoil 9 minutes ago
Yep, all of the pumped up bullchit has been debunked, . Zero revenues and huge debt is what is going on here.
ASRE
Hosai Hosai 9 minutes ago
We already have the results for AVXL, they were strong other than for an end point the FDA now say isn't required because it's too hard to show.
So what's the point in taking a chance that SAVA has good results (especially when their early stage results have been called into question which is
AVXL
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutes ago
PLEASE Ren drop some news and take this to dollars
TGGI
TRUSTUNITS1000000 TRUSTUNITS1000000 11 minutes ago
Interesting drink design
FHBC
Omar8 Omar8 11 minutes ago
ANt4,



"Work-For-Hire Doctrine & Corporate Officers. Under the work-for-hire doctrine, an employee also serving as a corporate officer typically has a fiduciary duty to assign the patent rights for inventions created during his/her tenure to the company. To do otherwise
NNLX
TRUSTUNITS1000000 TRUSTUNITS1000000 12 minutes ago
Millions in sales a while back
FHBC
Monksdream Monksdream 12 minutes ago
WRNT will it grow more legs after 7:00
WRNT
HD2001 HD2001 12 minutes ago
If Nash took a lie detector test he'd break the machine the graft can't go that wide . Delay and deceive
XALL
TRUSTUNITS1000000 TRUSTUNITS1000000 13 minutes ago
Pull certs , what does that mean
AABB
learningcurve2020 learningcurve2020 13 minutes ago
BP doesn't need all this risky illegal land mines, they could buy broke tiny NWBO or Advent with the change in their pocket.
NWBO
MightyX MightyX 14 minutes ago
This move significantly diminishes inherent post-r/s risk
TPTW
TRUSTUNITS1000000 TRUSTUNITS1000000 15 minutes ago
Interesting marketing
VGID
TRUSTUNITS1000000 TRUSTUNITS1000000 15 minutes ago
Maybe they stopped selling drinks at trade shows
VGID
MightyX MightyX 15 minutes ago
Reflects huge long-term-investor gain overnight to offset retail bs.
TPTW

Your Recent History

Delayed Upgrade Clock